Fig. 1From: A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET studyFlow diagram depicting phases of the parallel randomized trial for empagliflozin and sitagliptin groups. FAS: full analysis setBack to article page